Japanese
menu-4
close
HOME
Business Operation
skip-track2
Global Development of CHP Cancer Protein Vaccines
Drug Discovery for Multifunctional Cancer DNA Vaccines
Drug Discovery of “Therapeutics for Immune Diseases” by Exploring Immune Regulatory Mechanism
About us
News Releases
Home
2013
2013年3月
ImmunoFrontier prepared the CSR of Phase I Study of CHP-NY-ESO-1 in patients with Malignancies Expressing NY-ESO 1 in US.
2013/03/29
up-arrow-1